Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kezar Life Sciences (KZR) Revenue (2021 - 2025)

Historic Revenue for Kezar Life Sciences (KZR) over the last 5 years, with Q2 2025 value amounting to -$302000.0.

  • Kezar Life Sciences' Revenue rose 2468.83% to -$302000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was -$649000.0, marking a year-over-year increase of 1897.63%. This contributed to the annual value of $7.0 million for FY2023, which is N/A changed from last year.
  • Latest data reveals that Kezar Life Sciences reported Revenue of -$302000.0 as of Q2 2025, which was up 2468.83% from -$347000.0 recorded in Q1 2025.
  • Over the past 5 years, Kezar Life Sciences' Revenue peaked at $7.0 million during Q3 2023, and registered a low of -$401000.0 during Q2 2024.
  • For the 5-year period, Kezar Life Sciences' Revenue averaged around $411000.0, with its median value being -$324500.0 (2025).
  • As far as peak fluctuations go, Kezar Life Sciences' Revenue crashed by 4566.93% in 2023, and later soared by 2468.83% in 2025.
  • Over the past 5 years, Kezar Life Sciences' Revenue (Quarter) stood at -$159000.0 in 2021, then crashed by 71.07% to -$272000.0 in 2022, then soared by 2673.53% to $7.0 million in 2023, then tumbled by 105.73% to -$401000.0 in 2024, then grew by 24.69% to -$302000.0 in 2025.
  • Its Revenue was -$302000.0 in Q2 2025, compared to -$347000.0 in Q1 2025 and -$401000.0 in Q2 2024.